Alternative investment funds managed by European regulated asset managers
The data shown is taken from a database provided by european regulators. Date of update: 2025-04-10
Fund type available: AIF, ELTIF, EuSEF and EuVECA.
Click on the Fund’s LEI for more information or Use our search module for additional data.
| Fund Manager Name | Fund Name | Fund Type | Fund Manager State | Fund Manager LEI | Fund LEI |
|---|---|---|---|---|---|
| PAI SAS | ASMODEE CO-INVEST S.L.P. | AIF | FRANCE | ||
| PAI SAS | PAI EUROPE VI-3 FPCI | AIF | FRANCE | ||
| PAI SAS | PAI EUROPE VI-1 FIPS | AIF | FRANCE | ||
| PAI SAS | LABEYRIE CO-INVEST FPCI | AIF | FRANCE | ||
| MNK PARTNERS FRANCE | ST MICHEL OPCI | AIF | FRANCE | ||
| MNK PARTNERS FRANCE | CUSTODIA | AIF | FRANCE | ||
| STARQUEST | STARQUEST ISF 2015-1 | AIF | FRANCE | ||
| STARQUEST | STARQUEST ISF 2014-4 | AIF | FRANCE | ||
| STARQUEST | STARQUEST ISF 2014-3 | AIF | FRANCE | ||
| STARQUEST | STARQUEST ISF 2013-6 | AIF | FRANCE | ||
| STARQUEST | STARQUEST ISF 2013-5 | AIF | FRANCE | ||
| STARQUEST | PALMARES STARQUEST 2016 | AIF | FRANCE | ||
| STARQUEST | FCPI STARQUEST DISCOVERY 2017 | AIF | FRANCE | ||
| STARQUEST | STARQUEST VENTURES | AIF | FRANCE | ||
| STARQUEST | STARQUEST ISF 2014-1 | AIF | FRANCE | ||
| STARQUEST | STARQUEST ANTI-FRAGILE 2015 | AIF | FRANCE | ||
| STARQUEST | STARQUEST CONVICTIONS 2017 | AIF | FRANCE | ||
| WORMSER FRERES GESTION | WF VENTURE LOAN | AIF | FRANCE | ||
| TRUFFLE CAPITAL S.A.S | FCPI FORTUNE 3 | AIF | FRANCE | ||
| JEITO CAPITAL | JEITO II S.L.P. | AIF | FRANCE | 969500AB4TPIQB0R7Q50 | 9695007UAGWQ2J4XH914 |
| IQ EQ Management | FOUNDERS FUTURE FUND I | AIF | FRANCE | ||
| ARCHIMED | MED ACCESS S.L.P. | AIF | FRANCE | 9695008GS04QJBETA603 | 969500ACTYZO4PXBK189 |
| BLACKROCK FRANCE S.A.S. | GLOBAL CREDIT OPPORTUNITIES II CO-INVEST FUND SCSP | AIF | FRANCE | 549300TDLE2H5WJL1K68 | |
| IQ EQ Management | EXPANSION INVEST 2023 | AIF | FRANCE | ||
| SOFIDY | ALMA PROPERTY | AIF | FRANCE |
Warning: The AIF funds listed here are reserved for professional or institutional investors. These products are not authorised for sale to the general public. Subscription by private individuals is prohibited, unless otherwise provided for by the regulations.